Your browser doesn't support javascript.
loading
Optimizing pediatric liver transplantation: Evaluating the impact of donor age and graft type on patient survival outcome.
Kwon, Yong K; Valentino, Pamela L; Healey, Patrick J; Dick, Andre A S; Hsu, Evelyn K; Perkins, James D; Sturdevant, Mark L.
Afiliação
  • Kwon YK; Division of Transplantation, Department of Surgery, University of Washington, Seattle, Washington, USA.
  • Valentino PL; Division of Transplantation, Seattle Children's Hospital, Seattle, Washington, USA.
  • Healey PJ; Department of Surgery, Clinical and Bio-Analytics Transplant Laboratory, University of Washington, Seattle, Washington, USA.
  • Dick AAS; Division of Gastroenterology and Hepatology, Department of Pediatrics, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, Washington, USA.
  • Hsu EK; Division of Transplantation, Department of Surgery, University of Washington, Seattle, Washington, USA.
  • Perkins JD; Division of Transplantation, Seattle Children's Hospital, Seattle, Washington, USA.
  • Sturdevant ML; Department of Surgery, Clinical and Bio-Analytics Transplant Laboratory, University of Washington, Seattle, Washington, USA.
Pediatr Transplant ; 28(4): e14771, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38702924
ABSTRACT

BACKGROUND:

We examined the combined effects of donor age and graft type on pediatric liver transplantation outcomes with an aim to offer insights into the strategic utilization of these donor and graft options.

METHODS:

A retrospective analysis was conducted using a national database on 0-2-year-old (N = 2714) and 3-17-year-old (N = 2263) pediatric recipients. These recipients were categorized based on donor age (≥40 vs <40 years) and graft type. Survival outcomes were analyzed using the Kaplan-Meier and Cox proportional hazards models, followed by an intention-to-treat (ITT) analysis to examine overall patient survival.

RESULTS:

Living and younger donors generally resulted in better outcomes compared to deceased and older donors, respectively. This difference was more significant among younger recipients (0-2 years compared to 3-17 years). Despite this finding, ITT survival analysis showed that donor age and graft type did not impact survival with the exception of 0-2-year-old recipients who had an improved survival with a younger living donor graft.

CONCLUSIONS:

Timely transplantation has the largest impact on survival in pediatric recipients. Improving waitlist mortality requires uniform surgical expertise at many transplant centers to provide technical variant graft (TVG) options and shed the conservative mindset of seeking only the "best" graft for pediatric recipients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doadores de Tecidos / Transplante de Fígado / Estimativa de Kaplan-Meier / Sobrevivência de Enxerto Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Pediatr Transplant Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doadores de Tecidos / Transplante de Fígado / Estimativa de Kaplan-Meier / Sobrevivência de Enxerto Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Pediatr Transplant Ano de publicação: 2024 Tipo de documento: Article